Video
Dr. Lowentritt discusses phase 3 SPOTLIGHT trial on new PSMA-PET tool
Author(s):
"The idea that we may have reliable and consistently interpretable tests for these patients is exciting for the future," says Benjamin Lowentritt, MD, FACS.
In this interview, Benjamin Lowentritt, MD, FACS, recaps key findings from the phase 3 SPOTLIGHT trial data that were presented at the 2022 ASTRO Annual Meeting. He is currently a practicing urologist at Chesapeake Urology in Baltimore, Maryland.
Related Videos
Related Content
